A monthly price is useful only if you know what happens when you pay it. Fitish RX makes part of that calculation straightforward: it publishes prices for compounded semaglutide with B6, compounded injectable tirzepatide and oral tirzepatide tablets, with consultation, medication if approved and shipping included. What the consulted documents do not settle is equally important for a household budget: whether bundles require advance payment, when another charge occurs and what money is returned if treatment does not proceed.
This documentary review examines Fitish RX as a cash-pay telehealth provider, using sources consulted October 19, 2026—not necessarily updated that day. Its advertised service includes online intake, clinical review, pharmacy fulfillment and portal follow-up. The central cost distinction is between a clearly displayed product price and a fully documented payment agreement. Fitish RX supplies the former more convincingly than the latter, particularly for longer bundles and a separate microdosing program whose page uses both monthly and 28-day descriptions.
At a glance
- Semaglutide with B6
- Compounded semaglutide + B6 is advertised at $219 for a monthly supply, including consultation, medication if approved and shipping, with no separate consultation or membership fees.Sources: [8]
- Two tirzepatide presentations
- Compounded injectable tirzepatide and oral tirzepatide tablets each list $339 for a monthly supply, including consultation, medication if approved and shipping.
- Bundle pricing
- Three- and six-month bundles list lower monthly amounts, but the consulted documents do not clarify upfront collection, the total payable or a minimum commitment.
- Microdosing interval
- The separate microdosing page lists semaglutide at $179 and tirzepatide at $269 for a 28-day supply, while also using a monthly description. Additional discounts are excluded.Sources: [15]
Start with the amount due, not the smallest monthly figure
Fitish RX describes itself as a telehealth wellness clinic and says it operates on a cash-pay basis rather than accepting insurance. Its standard product pages label prices as applying to a monthly supply and require a medical evaluation and prescription. Those are published service prices, not evidence that everyone who pays will receive medication. The distinction matters because the supplied material does not explain the financial outcome when a clinician declines to prescribe.
The standard listings are not expressly presented as first-month introductory offers. However, that does not establish a permanent rate: the website terms say prices may change without notice. Nor does a monthly supply description identify the precise debit date, renewal authorization or length of a billing cycle. Before comparing Fitish RX with another service, ask for the amount collected today and the amount and date of the next potential charge.
Bundles create another layer of uncertainty because a displayed monthly equivalent is not necessarily a monthly payment option. The supplied documents do not establish whether the first payment equals one month's advertised amount or a larger bundle charge. Our guide to understanding the first GLP-1 payment explains that distinction. Here, a written checkout quote would be more useful than assuming the lowest displayed figure is the immediate charge.
| Offering | Published price and period | Important condition |
|---|---|---|
| Compounded semaglutide + B6 | $219 per monthly supply; three-month bundle $195/month; six-month bundle $175/month | Medical evaluation and prescription required; bundle collection terms unclear |
| Compounded subcutaneous tirzepatide | $339 per monthly supply; three-month bundle $305/month; six-month bundle $270/month | Medical evaluation and prescription required; bundle collection terms unclear |
| Oral tirzepatide tablets | $339 per monthly supply; three-month bundle $305/month; six-month bundle $270/month | Medical evaluation and prescription required; not an FDA-approved oral product |
| Microdosing semaglutide | $179 per 28-day supply; page also uses monthly wording | Separate wellness/cosmetic program; no additional discounts |
| Microdosing tirzepatide | $269 per 28-day supply; page also uses monthly wording | Separate wellness/cosmetic program; no additional discounts |
What the standard prices actually include
Compounded semaglutide with B6 is listed at $219 for a monthly supply. Fitish RX explicitly includes the provider consultation, medication if approved and shipping, and says there are no separate consultation or membership fees. This is a meaningful disclosure: the advertised figure is not merely an access fee that leaves the listed medication to be purchased separately. Still, the consulted material does not specify whether laboratory testing, administration supplies or outside services are included.
Compounded tirzepatide is listed at $339 for a monthly supply, with the same consultation, conditional medication and shipping inclusions and no separate consultation or membership fees. Its product page identifies subcutaneous injection. Oral tirzepatide tablets also cost $339 for a monthly supply and include consultation, medication if approved and shipping. These are different presentations at the same advertised price, not interchangeable products whose clinical performance can be inferred from matching dollar amounts.
The useful comparison is therefore product plus documented services, not simply semaglutide versus tirzepatide by price. Ask for an itemized confirmation of anything needed outside the advertised package, including whether a separate laboratory or pharmacy transaction could arise. Our explanation of what a program price includes provides a framework, but the provider's own written answer should determine the budget. Included shipping does not resolve possible expenses associated with testing or treatment supplies.
Bundles reduce the advertised monthly amount, not the unanswered questions
For compounded semaglutide with B6, Fitish RX advertises a three-month bundle at $195 per month and a six-month bundle at $175 per month. Both injectable and oral tirzepatide list three-month bundles at $305 per month and six-month bundles at $270 per month. The pages say bundle pricing is applied during intake. They advertise 10% savings for three-month bundles and 20% for six-month bundles; those are the provider's claims, not independently calculated savings here.
The missing payment mechanics are material. The supplied pages do not establish whether these bundles are paid monthly or collected upfront, what total becomes payable at enrollment, or whether a minimum commitment applies. A three- or six-month label also does not establish how much medication ships at once. It should not be read as proof of either one large shipment or a particular supply quantity, especially where the tirzepatide page separately describes monthly shipping.
Someone considering a bundle should request a payment schedule and an explanation of what happens if clinical circumstances change before its stated duration ends. The terms permitting price changes do not establish whether an accepted bundle receives any price protection. Likewise, the published monthly figures do not explain renewal pricing after a bundle. A lower monthly equivalent is useful only alongside clear collection, continuation and unused-treatment terms; none should be inferred from the bundle name.
Microdosing is a separate offer with a different time unit
Fitish RX's microdosing page opens with a starting price of $179 and monthly-supply wording, but later specifies a 28-day supply: $179 for semaglutide and $269 for tirzepatide. Both require medical evaluation and a prescription. Twenty-eight days is four weeks, not a calendar month. The page's inconsistent interval descriptions make it important to confirm the actual supply period and charge frequency rather than treating its lowest price as directly comparable with the standard monthly programs.
The program also excludes additional discounts because Fitish RX says its rate is already discounted. More importantly, its stated purpose differs: the dedicated page describes general wellness and cosmetic support and explicitly says it is not a weight-loss or weight-management program. Elsewhere, the GLP-1 pages suggest that some people below the standard program's BMI threshold might be considered for microdosing after clinical review. That presentation deserves clarification, not an assumption of eligibility.
For cost comparison, this is not simply a cheaper version of the standard weight-management service. Ask which program is being proposed, its documented purpose, its formulation and route, and what services accompany the quoted amount. Marketing references to metabolic, appetite or longevity benefits are provider claims, not demonstrated outcomes for this program in the supplied evidence. Our guide to monthly and four-week billing explains why the interval itself belongs in any comparison.
The consultation and follow-up behind the payment
The described enrollment process begins with a short online intake about health and goals, followed by review by a licensed provider. Fitish RX says telehealth access does not require an in-person visit and that a prescription follows only when clinically appropriate. Its weight-management eligibility description refers to adults whose BMI and medical history meet clinical criteria, without publishing numeric thresholds in the supplied material. Its privacy policy says it does not knowingly provide services to people under 18.
The advertised ongoing service includes regular check-ins, progress tracking and direct care-team messaging. The tirzepatide page specifically says portal support for questions and clinician-directed adjustments comes at no added cost. That is a useful included-service statement, but it does not establish a response-time guarantee, round-the-clock staffing or a fixed appointment schedule. The documents also do not settle whether a particular laboratory assessment or external referral would create another expense.
Responsibility is split across named entities rather than resting solely with the visible brand. The privacy notice identifies Fitish, LLC together with DrTelx, described as the affiliated professional entity whose licensed providers deliver care through the website; the website terms name FITISH as operator. These are documentary descriptions, not independently verified credentials. Before paying, ask who handles prescribing, clinical messages and billing disputes, since those responsibilities can require different contacts.
Pharmacy fulfillment and the limits of a price comparison
Fitish RX says compounded semaglutide comes from a state-licensed sterile compounding pharmacy. Its tirzepatide page describes discreet shipping from a licensed compounding pharmacy on a monthly cadence. The supplied documents do not name the dispensing pharmacies or establish state-by-state availability. General terms reserve the ability to restrict sales by geography or jurisdiction. A Texas mailing address therefore should not be mistaken for either a nationwide service promise or a complete description of where care is available.
Product status also belongs in the value calculation. Fitish RX discloses that its compounded oral tirzepatide is not FDA approved and that there is no FDA-approved oral tirzepatide product. FDA explains that compounded preparations do not receive its premarket review for safety, effectiveness and quality. Nonapproval alone does not prove clinical inequivalence, but approval of a specific commercial product does not extend to this clinic, its compounded preparations, vitamin blends or alternative routes.
FDA recommends compounded drugs for patients whose medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. That is a reason to ask why the proposed preparation fits the clinical need, not a categorical legal conclusion about this service. Published trials of other products do not establish Fitish RX outcomes. The supplied material also does not document an effective dispensing offer for the approved brand-name alternatives mentioned on its pages.
Cancellation language does not settle refunds or future charges
Fitish RX's website terms allow users to terminate those terms by notifying the company that they no longer want its services or by ceasing to use the site. That is not a detailed instruction for stopping treatment-related billing or pharmacy shipments. The supplied material does not identify an automatic-renewal schedule, cancellation deadline, pause procedure or treatment-specific confirmation process. Monthly shipping, by itself, proves neither a subscription agreement nor how to end one.
The terms also refer returns and exchanges to a Return Policy, but that policy is not part of the supplied pages. Consequently, the review cannot establish refunds following clinical denial, treatment discontinuation or unused supplies. Cancellation should not be treated as a promise of reimbursement. Similarly, replying STOP cancels the SMS service and triggers a final confirmation message; it is not documented as a way to cancel clinical services, future charges or medication shipments.
Before selecting a longer bundle, obtain written answers about the cancellation channel, the effective stop date and whether money already collected can be returned. Ask separately about an order already sent to the pharmacy and a shipment already dispatched. Our guide to cancellation and refund boundaries explains why these are separate questions. In this case, broad website termination language is not a substitute for a clear financial exit policy.
Use the published contacts to close the budget gaps
Fitish RX separates its contact routes: theclinic@fitish.com for treatment questions and product issues, orders@fitish.com for orders and existing patients, and info@fitish.com for general questions. It also publishes 1-800-576-8990 and a mailing address for Fitish, LLC at 2311 East Loop 820 North, Fort Worth, Texas 76118. These are useful contact paths, although the supplied material does not establish support hours, response times or Spanish-language clinical or administrative assistance.
For damaged, defective or incorrect orders, the site directs patients to theclinic@fitish.com, without specifying a guaranteed refund or replacement remedy. Shipping being included does not establish arrival timing, refrigeration standards or the resolution of a temperature problem. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy. That guidance should not be replaced by assumptions based on a package's appearance or shipping price.
A useful written inquiry would identify the exact product and ask for today's charge, the next charge, bundle payment options, included supplies, state availability and cancellation/refund terms. Request the dispensing pharmacy's name and delivery expectations as well. Fitish RX's privacy notice also recognizes access to health records, including electronic copies when readily producible, subject to exceptions and a possible reasonable cost-based fee. Record access is another documented service boundary, rather than proof that every administrative service is free.
Questions & answers
Does Fitish RX charge separately for the initial consultation?
Its standard semaglutide and injectable tirzepatide pages include consultation in the listed monthly supply price and explicitly exclude separate consultation or membership fees. Oral tirzepatide also includes consultation. The documents do not explain whether any payment is retained if clinical review does not result in a prescription, so confirm that before paying.
Must I prepay for a three- or six-month Fitish RX bundle?
The consulted pages do not say. They publish monthly bundle amounts and say pricing is applied during intake, but do not establish upfront collection, a monthly payment alternative, the total immediately payable or a minimum commitment. Ask for the actual payment schedule rather than treating the displayed monthly equivalent as the checkout charge.
Can I use insurance for Fitish RX?
Fitish RX says it does not accept insurance and operates as a cash-pay telehealth service. That statement should guide expectations for its advertised plans. Separately, NIDDK notes that insurance coverage for weight-management medications varies by plan; it does not establish reimbursement for this provider or its compounded products. Confirm any proposed coverage directly with the insurer.
Is the $179 microdosing offer a monthly weight-loss plan?
Not as its dedicated page describes it. The page calls the program general wellness and cosmetic support, not weight loss or weight management. It lists semaglutide at $179 for 28 days while also using monthly wording, and excludes additional discounts. Confirm the actual interval, program purpose and proposed formulation before using that figure in a comparison.
Is Fitish RX's oral tirzepatide an FDA-approved tablet?
No. Fitish RX itself says its compounded oral tirzepatide is not FDA approved and that no FDA-approved oral tirzepatide product exists. FDA approval belongs to specific products, not the clinic. The matching $339 monthly price for oral and injectable offerings does not demonstrate equivalent clinical effects or make their evidence interchangeable.
Who should I contact about a charge or a damaged shipment?
Orders and existing-patient inquiries go to orders@fitish.com; treatment and product issues, including damaged, defective or incorrect orders, go to theclinic@fitish.com. The published phone number is 1-800-576-8990. The contact page does not promise a particular refund or replacement outcome. For a warm or inadequately refrigerated injectable, FDA advises not using it and contacting the provider or pharmacy.
Our assessment
Fitish RX offers useful price transparency at the product level: named compounded offerings, published monthly amounts and explicit inclusion of consultation, conditional medication and shipping. Its portal-support description also gives patients something concrete to ask about beyond the prescription. The financial documentation is less complete where a decision becomes harder to reverse: bundle collection, renewal timing, cancellation and refunds. The separate microdosing offer adds an interval inconsistency and a different stated purpose, so its lower price should not serve as a shortcut for comparing weight-management plans. A practical next step is a written, product-specific quote that answers those gaps and identifies the dispensing pharmacy. Until then, the published figures support an initial comparison, but not a confident estimate of the first payment or the financial consequences of stopping.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Fitish RX — faqs ↗
- Fitish RX — legal/sms terms ↗
- Fitish RX — legal/notice of privacy practices ↗
- Fitish RX — products/compounded semaglutide ↗
- Fitish RX — legal/terms ↗
- Fitish RX — legal/contact us ↗
- Fitish RX — products/oral tirzepatide ↗
- Fitish RX — legal/privacy policy ↗
- Fitish RX — about ↗
- Fitish RX — products/compounded tirzepatide ↗
- Fitish RX — products/glp 1 microdosing ↗